Search

The article discusses various issues concerning lipid modification in relation to cardiovascular disease (CVD). It cites the guidance on lipid modification published by Great Britain National Institute for Clinical Excellence (NICE). An explanation on the value of lipid modification in the primary prevention of CVD is offered, along with the factors that affect cholesterol measurement. The article also discusses the pharmacological management of CVD.

The article reports that practice nurses in Great Britain will be expected to hit tough new targets on the identification of people at risk of cardiovascular disease (CVD) and for lipid modification, following the publication of new guidance from the National Institute for Clinical Excellence (NICE). NICE says that practices must adopt a more systematic strategy to identify people who are likely to be at high risk of CVD.